Publications by authors named "Jessica Merz"
Article Synopsis
- Researchers have developed a new prognostic score called the Munich Sorafenib Evaluation (M-SE) score to improve treatment outcomes for patients with systemic HCC treated with sorafenib.
- The M-SE score was created based on a study of 108 patients and validated in an independent cohort of 101 patients, demonstrating superior performance over existing prognostic systems.
- Key prognostic factors for the M-SE score include the presence of ascites, tumor burden in the liver, and GOT levels, with distinct survival times observed across three stages of the score.
